Jennifer Kane

Head of Pharmacovigilance, Executive Director @Innoviva Specialty Therapeutics, Inc.

Littleton, MA, US

EMAILS

[email protected]

MOBILE NUMBERS

+17•••••••19

Reveal Contact Details

Signup · Get unlimited contacts

WORK HISTORY

Feb 2026 — Present

Head of Pharmacovigilance, Executive Director @Innoviva Specialty Therapeutics, Inc.

View department →

EDUCATION

1999 — 2001

Simmons University

BSN, Nursing

1993 — 1997

Virginia Tech

BS, Biology

2011

Northeastern University

MS in Drug Regulatory Affairs (some coursework completed)

SKILLS

CardiologySpeaking EngagementsGood Clinical Practice (Gcp)CRO ManagementData AnalysisClinical Study DesignGxpPowerpointMicrosoft ExcelTraining & DevelopmentMedical AffairsPresenterInfectious DiseasesTechnical TrainingProtocolIch-GcpCRODrug DevelopmentExcelGcpRegulatory SubmissionsU.s. Food and Drug Administration (Fda)Clinical TrialsHealthcareHospitalsClinical OperationsRegulatory DocumentationClinical ResearchPharmaceuticalsRegulatory RequirementsIndOutcomes ResearchNdaPharmacovigilanceEdcPharmacologyRegulatory AffairsPublic SpeakingEmployee TrainingEctd

ABOUT JENNIFER KANE

Expertise in: Compliance monitoring and process improvement Inspection management Global safety operations and risk management including: Standard Operating Procedure development Strategic vendor partnership management, Global regulations and guidance including ICH and CIOMS Phase I-IV clinical trials and post-market surveillance NDA development and submissionSpecialties: Process evaluation and development, compliance management, training development and presentations

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.